Latest News
Currency
InvestmentEyes on Asia: Merck and BioNTech land Chinese bispecifics
Eyes on Asia: Merck and BioNTech land Chinese bispecifics
BioXconomy presents the Asia biopharma and healthcare dealmaking and financing news for the week ending 29 November.
Subscribe to Our Newsletters
Stay updated and receive your insights for life sciences investment, innovation and partnering directly in your inbox.
C-Suite Conversations
See all
.png?width=800&auto=webp&quality=80&disable=upscale){kind=logo}
Europe's Largest Springtime Biotech Partnering Event
REGISTERNews from APAC
See all
partneringONE’s first-in-class partnering technology powers global events and enhances your networking experience.
To protect the future of healthcare, we need to be data-driven
Better data equals better solutions said panelists at LSX Nordics Congress, but collaborations must create behavioral changes to drive innovation.
From Series A to B: Navigating the transition from promise to proof
Investors at LSX Investival discuss how, after securing Series A funding, biotech companies should begin to lay the groundwork for Series B financing.
Picky pharma prone to better proven partners amid dealmaking downturn
Pharma is being more selective in the deals it strikes among what a panel of experts say is an abundance of players looking to partner.
